Amp-activated protein kinase in muscle growth, fat deposition, and meat quality

Applied Muscle Biology and Meat Science

Volumn , Issue , 2009, Pages 195-216

  Du, Min ^a   Shen, Qingwu W ^a   Underwood, Keith R ^a   Tong, Jun F ^a   Zhu, Meijun ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85013295659     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (214)

1. Abu-Elheiga, L., W.R. Brinkley, L. Zhong, S.S. Chirala, G. Woldegiorgis, and S.J. Wakil. 2000. The subcellular localization of acetyl-CoA carboxylase 2. Proc. Natl. Acad. Sci. U.S.A. 97:1444-1449.
2. Abuelheiga, L., A. Jayakumar, A. Baldini, S.S. Chirala, and S.J. Wakil. 1995. Human acetyl-CoA carboxylase — characterization, molecular-cloning, and evidence for 2 isoforms. Proc. Natl. Acad. Sci. U.S.A. 92:4011-4015.
3. Aguilar, V., S. Alliouachene, A. Sotiropoulos, A. Sobering, Y. Athea, F. Djouadi, S. Miraux, E. Thiaudiere, M. Foretz, B. Viollet, P. Diolez, J. Bastin, P. Benit, P. Rustin, D. Carling, M. Sandri, R. Ventura-Clapier, and M. Pende. 2007. S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. Cell Metab. 5:476-487.
4. Anderson, K.A., RL. Means, Q.H. Huang, B.E. Kemp, E.G. Goldstein, M.A. Selbert, A.M. Edelman, R.T. Fremeau, and A.R. Means. 1998. Components of a calmodulin-dependent protein kinase cascade. Molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase beta. J. Biol. Chem. 273:31880-31889.
5. Andersson, L. 2003. Identification and characterization of AMPK gamma 3 mutations in the pig. Biochem. Soc. Trans. 31:232-235.
6. Andersson, U., K. Filipsson, C.R. Abbott, A. Woods, K. Smith, S.R. Bloom, D. Carling, and C. J. Small. 2004. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279:12005-12008.
7. Arad, M., D.W. Benson, A.R. Perez-Atayde, W.J. McKenna, E.A. Sparks, R.J. Kanter, K. McGarry, J.G. Seidman, and C.E. Seidman. 2002. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J. Clin. Invest. 109:357-362.
8. Artaza, J.N., S. Bhasin, T.R. Magee, S. Reisz-Porszasz, R. Shen, N.P. Groome, M.F. Meerasahib, and N.F. Gonzalez-Cadavid. 2005. Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology 146:3547-3557.
9. Ashrafian, H., C. Redwood, E. Blair, and H. Watkins. 2003. Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion. Trends Genet. 19:263-268.
10. Banerjee, R.R., S.M. Rangwala, J.S. Shapiro, A.S. Rich, B. Rhoades, Y. Qi, J. Wang, M.W. Rajala, A. Pocai, P.E. Scherer, C.M. Steppan, R.S. Ahima, S. Obici, L. Rossetti, and M. A. Lazar. 2004. Regulation of fasted blood glucose by resistin. Science 303:1195-1198.
11. Barnes, K., J.C. Ingram, O.H. Porras, L.F. Barros, E.R. Hudson, L.G.D. Fryer, F. Foufelle, D. Carling, D.G. Hardie, and S.A. Baldwin. 2002. Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J. Cell Sci. 115:2433-2442.
12. Beg, Z.H., D.W. Allmann, and D.M. Gibson. 1973. Modulation of 3-hydroxy-3-methylglutaryl Coenzyme A reductase-activity with cAMP and with protein fractions of rat-liver cytosol. Biochem. Biophys. Res. Commun. 54:1362-1369.
13. Bergeron, R., R.R. Russell, L.H. Young, J.M. Ren, M. Marcucci, A. Lee, and G.I. Shulman. 1999. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am. J. Physiol. -Endocrinol. Metab. 276:E938-E944.
14. Beri, R.K., A.E. Marley, C.G. See, W.F. Sopwith, K. Aguan, D. Carling, J. Scott, and F. Carey. 1994. Molecularcloning, expression and chromosomal localization of human AMP-activated. FEBS Lett. 356:117-121.
15. Bodine, S.C., E. Latres, S. Baumhueter, V.K. Lai, L. Nunez, B.A. Clarke, W.T. Poueymirou, F.J. Panaro, E. Na, K. Dharmarajan, Z.Q. Pan, D.M. Valenzuela, T.M. DeChiara, T.N. Stitt, G.D. Yancopoulos, and D.J. Glass. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704-1708.
16. Browne, G.J., S.G. Finn, and C.G. Proud. 2004. Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, Serine 398. J. Biol. Chem. 279:12220-12231.
17. Browne, G.J. and C.G. Proud. 2002. Regulation of peptide-chain elongation in mammalian cells. Eur. J. Biochem. 269:5360-5368.
18. Browne, G.J. and C.G. Proud. 2004. A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin. Mol. Cell. Biol. 24:2986-2997.
19. Bush, J.A., S.R. Kimball, P.M. O’Connor, A. Suryawan, R.A. Orellana, H.V. Nguyen, L.S. Jefferson, and T.A. Davis. 2003. Translational control of protein synthesis in muscle and liver of growth hormone-treated pigs. Endocrinology 144:1273-1283.
20. Cagnazzo, M., M.F. te Pas, J. Priem, A.A. de Wit, M.H. Pool, R. Davoli, and V. Russo. 2006. Comparison of prenatal muscle tissue expression profiles of two pig breeds differing in muscle characteristics. J. Anim. Sci. 84:1-10.
21. Carlberg, U., A. Nilsson, and O. Nygard. 1990. Functional properties of phosphorylated elongation factor-II. Eur. J. Biochem. 191:639-645.
22. Carling, D. 2004. The AMP-activated protein kinase cascade — a unifying system for energy control. Trends Biochem. Sci. 29:18-24.
23. Carling, D., P.R. Clarke, V.A. Zammit, and D.G. Hardie. 1989. Purification and characterization of the AMPactivated protein kinase — copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur. J. Biochem. 186:129-136.
24. Carling, D., V.A. Zammit, and D.G. Hardie. 1987. A common bicyclic protein-kinase cascade inactivates the regulatory enzymes of fatty-acid and cholesterol-biosynthesis. FEBS Lett. 223:217-222.
25. Carlson, C.A. and K. Kim. 1973. Regulation of hepatic acetyl coenzyme-A carboxylase by phosphorylation and dephosphorylation. J. Biol. Chem. 248:378-380.
26. Carr, C.C., J.B. Morgan, E.P. Berg, S.D. Carter, and F.K. Ray. 2006. Growth performance, carcass composition, quality, and enhancement treatment of fresh pork identified through deoxyribonucleic acid markerassisted selection for the Rendement Napole gene. J. Anim. Sci. 84:910-917.
27. Casteilla, L., C. Forest, J. Robelin, D. Ricquier, A. Lombet, and G. Ailhaud. 1987. Characterization of mitochondrial-uncoupling protein in bovine fetus and newborn calf. Am. J. Physiol. 252:E627-636.
28. Cheng, S.W., L.G. Fryer, D. Carling, and P.R. Shepherd. 2004. Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J. Biol. Chem. 279:15719-15722.
29. Cheng, Z., T. Pang, M. Gu, A.H. Gao, C.M. Xie, J.Y. Li, F.J. Nan, and J. Li. 2006. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochim. Biophys. Acta 1760:1682-1689.
30. Cheung, P.C.F., I.P. Salt, S.P. Davies, D.G. Hardie, and D. Carling. 2000. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem. J. 346:659-669.
31. Chiang, G.G. and R.T. Abraham. 2005. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J. Biol. Chem. 280:25485-25490.
32. Corradetti, M.N., K. Inoki, N. Bardeesy, R.A. DePinho, and K.L. Guan. 2004. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev. 18:1533-1538.
33. Corton, J.M., J.G. Gillespie, S.A. Hawley, and D.G. Hardie. 1995. 5-Aminoimidazole-4-carboxamide ribonucleoside — a specific method for activating AMP-activated protein-kinase in intact-cells. Eur. J. Biochem. 229:558-565.
34. Cross, D.A., D.R. Alessi, P. Cohen, M. Andjelkovich, and B.A. Hemmings. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789.
35. Crute, B.E., K. Seefeld, J. Gamble, B.E. Kemp, and L.A. Witters. 1998. Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase. J. Biol. Chem. 273:35347-35354.
36. Dagon, Y., Y. Avraham, and E.M. Berry. 2006. AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2 alpha in adipocytes. Biochem. Biophys. Res. Commun. 340:43-47.
37. Daniel, T. and D. Carling. 2002. Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome. J. Biol. Chem. 277:51017-51024.
38. Daval, M., F. Diot-Dupuy, R. Bazin, I. Hainault, B. Viollet, S. Vaulont, E. Hajduch, P. Ferre, and F. Foufelle. 2005. Antilipolytic action of AMP-activated protein kinase in rodent adipocytes. J. Biol. Chem. 280:25250-25257.
39. Davies, S.P., N.R. Helps, P.T. Cohen, and D.G. Hardie. 1995. 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Lett. 377:421-425.
40. Davies, S.P., A.T.R. Sim, and D.G. Hardie. 1990. Location and function of 3 sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein-kinase. Eur. J. Biochem. 187:183-190.
41. Du, M., Q.W. Shen, and M.J. Zhu. 2005. Role of alpha-adrenoceptor signaling and AMP-activated protein kinase in glycolysis of postmortem skeletal muscle. J. Agric. Food Chem. 53:3235-3239.
42. Enfalt, A.C., K. Lundstrom, I. Hansson, S. Johansen, and P.E. Nystrom. 1997c. Comparison of non-carriers and heterozygous carriers of the RN(−) allele for carcass composition, muscle distribution and technological meat quality in Hampshire-sired pigs. Livestock Production Sci. 47:221-229.
43. Estrade, M., X. Vignon, E. Rock, and G. Monin. 1993. Glycogen hyperaccumulation in white muscle-fibers of RN− carrier pigs — a biochemical and ultrastructural study. Compar. Biochem. and Physiol. B -Biochem. Mol. Biol. 104:321-326.
44. Fahrenkrug, S.C., B.A. Freking, and T.P. Smith. 1999. Genomic organization and genetic mapping of the bovine PREF-1 gene. Biochem. Biophys. Res. Commun. 264:662-667.
45. Ferrer, A., C. Caelles, N. Massot, and F.G. Hegardt. 1985. Activation of rat-liver cytosolic 3-hydroxy-3-methylglutaryl Coenzyme A reductase kinase by adenosine 5′-monophosphate. Biochem. Biophysical. Res. Commun. 132:497-504.
46. Feve, B. 2005. Adipogenesis: cellular and molecular aspects. Best Pract. Res. Clin. Endocrinol. Metab. 19:483-499.
47. Foretz, M., D. Carling, C. Guichard, P. Ferre, and F. Foufelle. 1998. AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes. J. Biol. Chem. 273:14767-14771.
48. Fraser, H., G.D. Lopaschuk, and A.S. Clanachan. 1999. Alteration of glycogen and glucose metabolism in ischaemic and post-ischaemic working rat hearts by adenosine A(1) receptor stimulation. Br. J. Pharmacol. 128:197-205.
49. Fryer, L.G., A. Parbu-Patel, and D. Carling. 2002a. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277:25226-25232.
50. Fryer, L.G.D., F. Foufelle, K. Barnes, S.A. Baldwin, A. Woods, and D. Carling. 2002b. Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells. Biochem. J. 363:167-174.
51. Giri, S., R. Rattan, E. Haq, M. Khan, R. Yasmin, J.S. Won, L. Key, A.K. Singh, and I. Singh. 2006a. AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutr. Metab. 3:31-51.
52. Glass, D.J. 2005. Skeletal muscle hypertrophy and atrophy signaling pathways. Int. J. Biochem. Cell Biol. 37:1974-1984.
53. Gnanalingham, M.G., A. Mostyn, M.E. Symonds, and T. Stephenson. 2005. Ontogeny and nutritional programming of adiposity in sheep: potential role of glucocorticoid action and uncoupling protein-2. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289:R1407-1415.
54. Goll, D.E., V.F. Thompson, H. Li, W. Wei, and J. Cong. 2003. The calpain system. Physiol. Rev. 83:731-801.
55. Goodyear, L.J., P.Y. Chang, D.J. Sherwood, S.D. Dufresne, and D.E. Moller. 1996. Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Am. J. Physiol.271:E403-E408.
56. Ha, J., J.K. Lee, K.S. Kim, L.A. Witters, and K.H. Kim. 1996. Cloning of human acetyl-CoA carboxylase-beta and its unique features. Proc. Natl. Acad. Sci. U.S.A. 93:11466-11470.
57. Habinowski, S.A. and L.A. Witters. 2001a. The effects of AICAR on adipocyte differentiation of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 286:852-856.
58. Haddad, F. and G.R. Adams. 2004. Inhibition of MAP/ERK kinase prevents IGF-I-induced hypertrophy in rat muscles. J. Appl. Physiol. 96:203-210.
59. Halevy, O. and L.C. Cantley. 2004. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells. Exp. Cell Res. 297:224-234.
60. Hamilton, D.N., K.D. Miller, M. Ellis, F.K. McKeith, and E.R. Wilson. 2003. Relationships between longissimus glycolytic potential and swine growth performance, carcass traits, and pork quality. J. Anim. Sci. 81:2206-2212.
61. Hardie, D.G. 2007. Biochemistry. Balancing cellular energy. Science 315:1671-1672.
62. Hardie, D.G., and D. Carling. 1997. The AMP-activated protein kinase — fuel gauge of the mammalian cell? Eur. J. BioChem. 246:259-273.
63. Hardie, D.G., D. Carling, and M. Carlson. 1998. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67:821-855.
64. Hardie, D.G., D. Carling, and A.T.R. Sim. 1989. The AMP-activated protein-kinase — a multisubstrate regulator of lipid metabolism. Trends Biochem. Sci. 14:20-23.
65. Hardie, D.G. and S.A. Hawley. 2001. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23:1112-1119.
66. Hardie, D.G., S.A. Hawley, and J. Scott. 2006. AMP-activated protein kinase — development of the energy sensor concept. J. Physiol. -London 574:7-15.
67. Hardie, D.G., I.P. Salt, S.A. Hawley, and S.P. Davies. 1999. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem. J. 338: 717-722.
68. Hardie, D.G., J.W. Scott, D.A. Pan, and E.R. Hudson. 2003. Management of cellular energy by the AMPactivated protein kinase system. FEBS Lett. 546:113-120.
69. Hardt, S.E. and J. Sadoshima. 2002. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circulation Res. 90:1055-1063.
70. Hawley, S.A., J. Boudeau, J.L. Reid, K.J. Mustard, L. Udd, T.P. Makela, D.R. Alessi, and D.G. Hardie. 2003. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2:28.
71. Hawley, S.A., M. Davison, A. Woods, S.P. Davies, R.K. Beri, D. Carling, and D.G. Hardie. 1996. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271:27879-27887.
72. Hawley, S.A., A.E. Gadalla, G.S. Olsen, and D.G. Hardie. 2002. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51:2420-2425.
73. Hawley, S.A., D.A. Pan, K.J. Mustard, L. Ross, J. Bain, A.M. Edelman, B.G. Frenguelli, and D.G. Hardie. 2005. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2:9-19.
74. Hawley, S.A., M.A. Selbert, E.G. Goldstein, A.M. Edelman, D. Carling, and D.G. Hardie. 1995. 5′-AMP activates the AMP-activated protein kinase cascade and Ca2+/calmodulin activates the calmodulin-dependent protein kinase-I cascade, via 3 independent mechanisms. J. Biol. Chem. 270:27186-27191.
75. Hayashi, T., M.F. Hirshman, N. Fujii, S.A. Habinowski, L.A. Witters, and L.J. Goodyear. 2000. Metabolic stress and altered glucose transport — activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 49:527-531.
76. Hayashi, T., M.F. Hirshman, E.J. Kurth, W.W. Winder, and L.J. Goodyear. 1998. Evidence for 5′AMPactivated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47:1369-1373.
77. Henin, N., M.F. Vincent, H.E. Gruber, and G. Vandenberghe. 1995. Inhibition of fatty-acid and cholesterolsynthesis by stimulation of AMP-activated protein-kinase. FASEB J. 9:541-546.
78. Holmes, B.F., E.J. Kurth-Kraczek, and W.W. Winder. 1999. Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J. Appl. Physiol. 87:1990-1995.
79. Hurley, R.L., K.A. Anderson, J.M. Franzone, B.E. Kemp, A.R. Means, and L.A. Witters. 2005. The Ca2+/ calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 280:29060-29066.
80. Hwang, J.T., I.J. Park, J.I. Shin, Y.K. Lee, S.K. Lee, H.W. Baik, J. Ha, and O.J. Park. 2005. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem. Biophys. Res. Commun. 338:694-699.
81. Inoki, K., T. Zhu, and K.L. Guan. 2003. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115:577-590.
82. Iverson, A.J., A. Bianchi, A.C. Nordlund, and L.A. Witters. 1990. Immunological analysis of acetyl-CoA carboxylase mass, tissue distribution and subunit composition. Biochem. J. 269:365-371.
83. Jakobsen, S.N., D.G. Hardie, N. Morrice, and H.E. Tornqvist. 2001. 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J. Biol. Chem. 276:46912-46916.
84. Jenne, D.E., H. Reimann, J. Nezu, W. Friedel, S. Loff, R. Jeschke, D. Muller, W. Back, and M. Zimmer. 1998. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nature Genetics 18:38-44.
85. Jensen, T.E., A.J. Rose, Y. Hellsten, J.F. Wojtaszewski, and E.A. Richter. 2007. Caffeine-induced Ca(2+) release increases AMPK-dependent glucose uptake in rodent soleus muscle. Am. J. Physiol. Endocrinol. Metab. 293:E286-E292.
86. Johnson, L.N., M.E. Noble, and D.J. Owen. 1996. Active and inactive protein kinases: structural basis for regulation. Cell 85:149-158.
87. Josell, A., A.C. Enfalt, G. von Seth, G. Lindahl, I. Hedebro-Velander, L. Andersson, and K. Lundstrom. 2003. The influence of RN genotype, including the new V199I allele, on the eating quality of pork loin. Meat Sci. 65:1341-1351.
88. Khamzina, L., A. Veilleux, S. Bergeron, and A. Marette. 2005. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146:1473-1481.
89. Kim, J.K., J.J. Fillmore, M.J. Sunshine, B. Albrecht, T. Higashimori, D.W. Kim, Z.X. Liu, T.J. Soos, G.W. Cline, W.R. O’Brien, D.R. Littman, and G.I. Shulman. 2004a. PKC-theta knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 114:823-827.
90. Kim, J.M., M. Yoon, I. Kang, S.S. Kim, and J. Ha. 1998. Evidence that acetyl-CoA carboxylase isoforms play different biological roles in H9c2 cardiomyocyte. Biochem. Biophys. Res. Commun. 248:490-496.
91. Kim, K.H., M.J. Song, J. Chung, H. Park, and J.B. Kim. 2005. Hypoxia inhibits adipocyte differentiation in a HDAC-independent manner. Biochem. Biophys. Res. Commun. 333:1178-1184.
92. Kim, M.S., J.Y. Park, C. Namkoong, P.G. Jang, J.W. Ryu, H.S. Song, J.Y. Yun, I.S. Namgoong, J. Ha, I.S. Park, I.K. Lee, B. Viollet, J.H. Youn, H.K. Lee, and K.U. Lee. 2004b. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nature Medicine 10:727-733.
93. Kimura, N., C. Tokunaga, S. Dalal, C. Richardson, K. Yoshino, K. Hara, B.E. Kemp, L.A. Witters, O. Mimura, and K. Yonezawa. 2003. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 8:65-79.
94. Krawiec, B.J., G.J. Nystrom, R.A. Frost, L.S. Jefferson, and C.H. Lang. 2007. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells. Am. J. Physiol. Endocrinol. Metab. 292:E1555-E1567.
95. Kurth-Kraczek, E.J., M.F. Hirshman, L.J. Goodyear, and W.W. Winder. 1999. 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48:1667-1671.
96. Larzul, C., P. Le Roy, G. Monin, and P. Sellier. 1998. Genetic variability of muscle glycolytic potential in pigs. Productions Animales 11:183-197.
97. Latres, E., A.R. Amini, A.A. Amini, J. Griffiths, F.J. Martin, Y. Wei, H. C. Lin, G.D. Yancopoulos, and D.J. Glass. 2005. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J. Biol. Chem. 280:2737-2744.
98. Le Roy, P., J.M. Elsen, J.C. Caritez, A. Talmant, H. Juin, P. Sellier, and G. Monin. 2000. Comparison between the three porcine RN genotypes for growth, carcass composition and meat quality traits. Genet. Select. Evolut. 32:165-186.
99. Lebret, B., L. Fefaucheur, and J. Mourot. 1999a. Pig meat quality. Influence of rearing factors on skeletal muscle traits. Productions Animales 12:11-28.
100. Lebret, B., P. Le Roy, G. Monin, L. Lefaucheur, J.C. Caritez, A. Talmant, J.M. Elsen, and P. Sellier. 1999b. Influence of the three RN genotypes on chemical composition, enzyme activities, and myofiber characteristics of porcine skeletal muscle. J. Anim. Sci. 77:1482-1489.
101. Leclerc, I., A. Kahn, and B. Doiron. 1998. The 5′-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex. FEBS Lett. 431:180-184.
102. Lee, W.J., K.H. Song, E.H. Koh, J.C. Won, H.S. Kim, H.S. Park, M.S. Kim, S.W. Kim, K.U. Lee, and J.Y. Park. 2005. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem. Biophys. Res. Commun. 332:885-891.
103. Lee, Y.S., W.S. Kim, K.H. Kim, M.J. Yoon, H.J. Cho, Y. Shen, J.M. Ye, C.H. Lee, W.K. Oh, C.T. Kim, C. Hohnen-Behrens, A. Gosby, E.W. Kraegen, D.E. James, and J.B. Kim. 2006. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulinresistant states. Diabetes 55:2256-2264.
104. Lehnert, S.A., A. Reverter, K.A. Byrne, Y. Wang, G.S. Nattrass, N.J. Hudson, and P.L. Greenwood. 2007. Gene expression studies of developing bovine longissimus muscle from two different beef cattle breeds. BMC Dev. Biol. 7:95.
105. Lessard, S.J., Z.P. Chen, M.J. Watt, M. Hashem, J.J. Reid, M.A. Febbraio, B.E. Kemp, and J.A. Hawley. 2006. Chronic rosiglitazone treatment restores AMPK alpha 2 activity in insulin-resistant rat skeletal muscle. Am. J. Physiol. -Endocrinol. Metab. 290:E251-E257.
106. Lizcano, J.M., O. Goransson, R. Toth, M. Deak, N.A. Morrice, J. Boudeau, S.A. Hawley, L. Udd, T.P. Makela, D.G. Hardie, and D.R. Alessi. 2004. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 23:833-843.
107. Lochhead, P.A., I.P. Salt, K.S. Walker, D.G. Hardie, and C. Sutherland. 2000. 5-Aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 49:896-903.
108. Lomax, M.A., F. Sadiq, G. Karamanlidis, A. Karamitri, P. Trayhurn, and D.G. Hazlerigg. 2007. Ontogenic loss of brown adipose tissue sensitivity to beta-adrenergic stimulation in the ovine. Endocrinology 148:461-468.
109. Mahlapuu, M., C. Johansson, K. Lindgren, G. Hjalm, B.R. Barnes, A. Krook, J.R. Zierath, L. Andersson, and S. Marklund. 2004. Expression profiling of the gamma-subunit isoforms of AMP-activated protein kinase suggests a major role for gamma 3 in white skeletal muscle. Am. J. Physiol. -Endocrinol. Metab. 286:E194-E200.
110. Marley, A.E., J.E. Sullivan, D. Carling, W.M. Abbott, G.J. Smith, I.W. Taylor, F. Carey, and R.K. Beri. 1996. Biochemical characterization and deletion analysis of recombinant human protein phosphatase 2C alpha. Biochem. J. 320(Pt. 3):801-806.
111. Marsin, A.S., L. Bertrand, M.H. Rider, J. Deprez, C. Beauloye, M.F. Vincent, G. Van den Berghe, D. Carling, and L. Hue. 2000. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr. Biol. 10:1247-1255.
112. McGarry, J.D. and N.F. Brown. 1997. The mitochondrial carnitine palmitoyltransferase system — from concept to molecular analysis. Eur. J. Biochem. 244:1-14.
113. McLoon, L.K., J. Rowe, J. Wirtschafter, and K.M. McCormick. 2004. Continuous myofiber remodeling in uninjured extraocular myofibers: myonuclear turnover and evidence for apoptosis. Muscle Nerve 29:707-715.
114. McManus, E.J. and D.R. Alessi. 2002. TSC1-TSC2: a complex tale of PKB-mediated S6K regulation. Nat. Cell Biol. 4:E214-216.
115. Mei, B., L. Zhao, L. Chen, and H.S. Sul. 2002. Only the large soluble form of preadipocyte factor-1 (Pref-1), but not the small soluble and membrane forms, inhibits adipocyte differentiation: role of alternative splicing. Biochem. J. 364:137-144.
116. Menconi, M.J., W. Wei, H. Yang, C.J. Wray, and P.O. Hasselgren. 2004. Treatment of cultured myotubes with the calcium ionophore A23187 increases proteasome activity via a CaMK II-caspase-calpain-dependent mechanism. Surgery 136:135-142.
117. Merrill, G.F., E.J. Kurth, D.G. Hardie, and W.W. Winder. 1997. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. -Endocrinol. Metab. 36:E1107-E1112.
118. Milan, D., J.T. Jeon, C. Looft, V. Amarger, A. Robic, M. Thelander, C. Rogel-Gaillard, S. Paul, N. Iannuccelli, L. Rask, H. Ronne, K. Lundstrom, N. Reinsch, J. Gellin, E. Kalm, P.L. Roy, P. Chardon, and L. Andersson. 2000. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 288:1248-1251.
119. Milan, D., N. Woloszyn, M. Yerle, P. LeRoy, M. Bonnet, J. Riquet, Y. LahbibMansais, J.C. Caritez, A. Robic, P. Sellier, J.M. Elsen, and J. Gellin. 1996. Accurate mapping of the “acid meat” RN gene on genetic and physical maps of pig Chromosome 15. Mammalian Genome 7:47-51.
120. Miller, K.D., M. Ellis, F.K. McKeith, B.S. Bidner, and D.J. Meisinger. 2000. Frequency of the Rendement Napole RN− allele in a population of American Hampshire pigs. J. Anim. Sci. 78:1811-1815.
121. Minokoshi, Y., T. Alquier, N. Furukawa, Y.B. Kim, A. Lee, B. Xue, J. Mu, F. Foufelle, P. Ferre, M.J. Birnbaum, B.J. Stuck, and B.B. Kahn. 2004. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428:569-574.
122. Minokoshi, Y., Y.B. Kim, O.D. Peroni, L.G. Fryer, C. Muller, D. Carling, and B.B. Kahn. 2002. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339-343.
123. Moeller, S.J., T.J. Baas, T.D. Leeds, R.S. Emnett, and K.M. Irvin. 2003. Rendement Napole gene effects and a comparison of glycolytic potential and DNA genotyping for classification of Rendement Napole status in Hampshire-sired pigs. J. Anim. Sci. 81:402-410.
124. Momcilovic, M., S.P. Hong, and M. Carlson. 2006. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J. Biol. Chem. 281:25336-25343.
125. Monin, G. and P. Sellier. 1985. Pork of low technological quality with a normal rate of muscle pH fall in the immediate post-mortem period: the case of the Hampshire breed. Meat Sci. 13:49-63.
126. Mu, J., J.T. Brozinick, O. Valladares, M. Bucan, and M.J. Birnbaum. 2001. A role for AMP-activated protein kinase in contraction-and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell 7:1085-1094.
127. Muhlhausler, B.S., J.A. Duffield, and I.C. McMillen. 2007. Increased maternal nutrition stimulates peroxisome proliferator activated receptor-γ (PPARγ), adiponectin and leptin mRNA expression in adipose tissue before birth. Endocrinology 148:878-885.
128. Munday, M.R., D.G. Campbell, D. Carling, and D.G. Hardie. 1988. Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase. Eur. J. BioChem. 175:331-338.
129. Muoio, D.M., K. Seefeld, L.A. Witters, and R.A. Coleman. 1999. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem. J. 338:783-791.
130. Murphy, R.T., J. Mogensen, K. McGarry, A. Bahl, A. Evans, E. Osman, P. Syrris, G. Gorman, M. Farrell, J.L. Holton, M.G. Hanna, S. Hughes, P.M. Elliott, C. A. Macrae, and W.J. McKenna. 2005. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history. J. Am. Coll. Cardiol. 45:922-930.
131. Muse, E.D., S. Obici, S. Bhanot, B.P. Monia, R.A. McKay, M.W. Rajala, P.E. Scherer, and L. Rossetti. 2004. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 114:232-239.
132. Musi, N., T. Hayashi, N. Fujii, M.F. Hirshman, L.A. Witters, and L.J. Goodyear. 2001. AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am. J. Physiol. -Endocrinol. Metab. 280:E677-E684.
133. Nakashima, K. and Y. Yakabe. 2007. AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes. Biosci. Biotechnol. Biochem. 71:1650-1656.
134. Oliveira, S.M., J. Ehtisham, C.S. Redwood, I. Ostman-Smith, E.M. Blair, and H. Watkins. 2003. Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis. J. Mol. Cell Cardiol. 35:1251-1255.
135. Owen, M.R., E. Doran, and A.P. Halestrap. 2000. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348:607-614.
136. Ozes, O.N., H. Akca, L.D. Mayo, J.A. Gustin, T. Maehama, J.E. Dixon, and D.B. Donner. 2001. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl. Acad. Sci. U.S.A. 98:4640-4645.
137. Packer, L., K. Kraemer, and G. Rimbach. 2001. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17:888-895.
138. Palanivel, R. and G. Sweeney. 2005. Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin. FEBS Lett. 579:5049-5054.
139. Pap, M. and G.M. Cooper. 2002. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway. Mol. Cell Biol. 22:578-586.
140. Park, H., V.K. Kaushik, S. Constant, M. Prentki, E. Przybytkowski, N.B. Ruderman, and A.K. Saha. 2002. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J. Biol. Chem. 277:32571-32577.
141. Park, I.H., E. Erbay, P. Nuzzi, and J. Chen. 2005. Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1. Exp. Cell Res. 309:211-219.
142. Park, I.J., J.T. Hwang, Y.M. Kim, J. Ha, and O.J. Park. 2006. Differential modulation of AMPK signaling pathways by low or high levels of exogenous reactive oxygen species in colon cancer cells. Ann. N.Y. Acad. Sci. 1091:102-109.
143. Peraldi, P. and B. Spiegelman. 1998. TNF-alpha and insulin resistance: summary and future prospects. Mol. Cell Biochem. 182:169-175.
144. Poulos, S.P. and G.J. Hausman. 2006. A comparison of thiazolidinedione-induced adipogenesis and myogenesis in stromal-vascular cells from subcutaneous adipose tissue or semitendinosus muscle of postnatal pigs. J. Anim. Sci. 84:1076-1082.
145. Qiao, L.Y., R. Zhande, T.L. Jetton, G. Zhou, and X.J. Sun. 2002. In vivo phosphorylation of insulin receptor substrate 1 at serine 789 by a novel serine kinase in insulin-resistant rodents. J. Biol. Chem. 277:26530-26539.
146. Rose, A.J., B. Kiens, and E.A. Richter. 2006. Ca2+-calmodulin-dependent protein kinase expression and signalling in skeletal muscle during exercise. J. Physiol. -London 574:889-903.
147. Russell, R.R., R. Bergeron, G.I. Shulman, and L.H. Young. 1999. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am. J. Physiol. -Heart Circulat. Physiol. 277:H643-H649.
148. Sabina, R.L., D. Patterson, and E.W. Holmes. 1985. 5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells. J. Biol. Chem. 260:6107-6114.
149. Sakamoto, K., O. Goransson, D.G. Hardie, and D.R. Alessi. 2004. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR. Am. J. Physiol. -Endocrinol. Metab. 287:E310-E317.
150. Sakamoto, K., A. McCarthy, D. Smith, K.A. Green, D.G. Hardie, A. Ashworth, and D.R. Alessi. 2005. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J. 24:1810-1820.
151. Sakamoto, K., E. Zarrinpashneh, G.R. Budas, A.C. Pouleur, A. Dutta, A.R. Prescott, J.L. Vanoverschelde, A. Ashworth, A. Jovanovic, D.R. Alessi, and L. Bertrand. 2006. Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPK alpha 2 but not AMPK alpha 1. Am. J. Physiol. -Endocrinol. Metab. 290:E780-E788.
152. Sakoda, H., T. Ogihara, M. Anai, M. Fujishiro, H. Ono, Y. Onishi, H. Katagiri, M. Abe, Y. Fukushima, N. Shojima, K. Inukai, M. Kikuchi, Y. Oka, and T. Asano. 2002. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes. Am. J. Physiol. -Endocrinol. Metab. 282:E1239-E1244.
153. Sanders, M.J., P.O. Grondin, B.D. Hegarty, M.A. Snowden, and D. Carling. 2007. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 403:139-148.
154. Satoh, H., M.T.A. Nguyen, P.D.G. Miles, T. Imamura, I. Usui, and J.M. Olefsky. 2004. Adenovirusmediated chronic “hyper-resistinemia” leads to in vivo insulin resistance in normal rats. J. Clin. Invest. 114:224-231.
155. Schulz, R.A. and K.E. Yutzey. 2004. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev. Biol. 266:1-16.
156. Scott, J.W., S.A. Hawley, K.A. Green, M. Anis, G. Stewart, G.A. Scullion, D.G. Norman, and D.G. Hardie. 2004. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J. Clin. Invest. 113:274-284.
157. Shaw, R.J. and L.C. Cantley. 2006. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441:424-430.
158. Shaw, R.J., M. Kosmatka, N. Bardeesy, R.L. Hurley, L.A. Witters, R.A. DePinho, and L.C. Cantley. 2004. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. U.S.A. 101:3329-3335.
159. Shaw, R.J., K.A. Lamia, D. Vasquez, S.H. Koo, N. Bardeesy, R.A. DePinho, M. Montminy, and L.C. Cantley. 2005. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310:1642-1646.
160. Shen, Q.W. and M. Du. 2005. Role of AMP-activated protein kinase in the glycolysis of postmortem muscle. J. Sci. Food Agric. 85:2401-2406.
161. Shen, Q.W., M. Du, and J. Ren. 2006a. Fitness and fatness: the debate continues for AMP activated protein kinase in heart function. Curr. Cardiol. Rev. 2:117-123.
162. Shen, Q.W., W.J. Means, S.A. Thompson, K.R. Underwood, M.J. Zhu, R.J. McCormick, S.P. Ford, and M. Du. 2006b. Pre-slaughter transport, AMP-activated protein kinase, glycolysis, and quality of pork loin. Meat Sci. 74:388-395.
163. Shen, Q.W., W.J. Means, K.R. Underwood, S.A. Thompson, M. J. Zhu, R. J. McCormick, S. P. Ford, M. Ellis, and M. Du. 2006c. Early post-mortem AMP-activated protein kinase (AMPK) activation leads to phosphofructokinase-2 and -1 (PFK-2 and PFK-1) phosphorylation and the development of pale, soft, and exudative (PSE) conditions in porcine longissimus muscle. J. Agric. Food Chem. 54:5583-5589.
164. Shen, Q.W., K.R. Underwood, W.J. Means, R.J. McCormick, and M. Du. 2007a. The halothane gene, energy metabolism, adenosine monophosphate-activated protein kinase, and glycolysis in postmortem pig longissimus dorsi muscle. J. Anim. Sci. 85:1054-1061.
165. Shen, Q.W., M.J. Zhu, J. Tong, J. Ren, and M. Du. 2007b. Ca2+/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by alpha-lipoic acid in C2C12 myotubes. Am. J. Physiol. Cell Physiol. 293:C1395-1403.
166. Shen, Q.W., W.J. Means, K.R. Underwood, S.A. Thompson, M.J. Zhu, R.J. McCormick, S.P. Ford, M. Ellis, and M. Du. 2006d. Early post-mortem AMP-activated protein kinase (AMPK) activation leads to phosphofructokinase-2 and-1 (PFK-2 and PFK-1) phosphorylation and the development of pale, soft, and exudative (PSE) conditions in porcine longissimus muscle. J. Agric. Food Chem. 54:5583-5589.
167. Sidhu, J.S., Y.S. Rajawat, T.G. Rami, M.H. Gollob, Z. Wang, R. Yuan, A.J. Marian, F.J. DeMayo, D. Weilbacher, G.E. Taffet, J.K. Davies, D. Carling, D.S. Khoury, and R. Roberts. 2005. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Circulation 111:21-29.
168. Skurk, C., Y. Izumiya, H. Maatz, P. Razeghi, I. Shiojima, M. Sandri, K. Sato, L. Zeng, S. Schiekofer, D. Pimentel, S. Lecker, H. Taegtmeyer, A.L. Goldberg, and K. Walsh. 2005. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J. Biol. Chem. 280:20814-20823.
169. Song, Y.H., M. Godard, Y. Li, S.R. Richmond, N. Rosenthal, and P. Delafontaine. 2005. Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation. J. Investig. Med. 53:135-142.
170. Spiegelman, B.M., P. Puigserver, and Z. Wu. 2000. Regulation of adipogenesis and energy balance by PPARgamma and PGC-1. Int. J. Obes. Relat. Metab. Disord. 24:S8-S10.
171. Spindler, M., K.W. Saupe, M.E. Christe, H.L. Sweeney, C.E. Seidman, J.G. Seidman, and J.S. Ingwall. 1998. Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J. Clin. Invest. 101:1775-1783.
172. Sriwijitkamol, A., J.L. Ivy, C. Christ-Roberts, R.A. DeFronzo, L.J. Mandarino, and N. Musi. 2006. LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training. Am. J. Physiol. Endocrinol. Metab. 290:E925-932.
173. Stapleton, D., K.I. Mitchelhill, G. Gao, J. Widmer, B.J. Michell, T. Teh, C.M. House, C.S. Fernandez, T. Cox, L.A. Witters, and B.E. Kemp. 1996. Mammalian AMP-activated protein kinase subfamily. J. Biol. Chem. 271:611-614.
174. Stapleton, D., E. Woollatt, K.I. Mitchelhill, J.K. Nicholl, C.S. Fernandez, B.J. Michell, L.A. Witters, D.A. Power, G.R. Sutherland, and B.E. Kemp. 1997. AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location. FEBS Lett. 409:452-456.
175. Stein, S.C., A. Woods, N.A. Jones, M.D. Davison, and D. Carling. 2000. The regulation of AMP-activated protein kinase by phosphorylation. Biochem. J. 345:437-443.
176. Steinberg, G.R., S.L. Macaulay, M.A. Febbraio, and B.E. Kemp. 2006a. AMP-activated protein kinase — the fat controller of the energy railroad. Can. J. Physiol. Pharmacol. 84:655-665.
177. Steinberg, G.R., B.J. Michell, B.J. van Denderen, M.J. Watt, A.L. Carey, B.C. Fam, S. Andrikopoulos, J. Proietto, C.Z. Gorgun, D. Carling, G.S. Hotamisligil, M.A. Febbraio, T.W. Kay, and B.E. Kemp. 2006b. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMPkinase signaling. Cell Metab. 4:465-474.
178. Steinberg, G.R., J.W. E. Rush, and D.J. Dyck. 2003. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment. Am. J. Physiol. -Endocrinol. Metab. 284:E648-E654.
179. Subramaniam, S., N. Shahani, J. Strelau, C. Laliberte, R. Brandt, D. Kaplan, and K. Unsicker. 2005. Insulinlike growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway. J. Neurosci. 25:2838-2852.
180. Sullivan, J.E., K.J. Brocklehurst, A.E. Marley, F. Carey, D. Carling, and R.K. Beri. 1994. Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett. 353:33-36.
181. Thornton, C., M.A. Snowden, and D. Carling. 1998. Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle. J. Biol. Chem. 273:12443-12450.
182. Tian, R., N. Musi, J. D’Agostino, M.F. Hirshman, and L.J. Goodyear. 2001. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 104:1664-1669.
183. Tomas, E., T.S. Tsao, A.K. Saha, H.E. Murrey, C. Zhang, S.I. Itani, H.F. Lodish, and N.B. Ruderman. 2002. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. U.S.A. 99:16309-16313.
184. Tong, J., M.J. Zhu, K.R. Underwood, B.W. Hess, S.P. Ford, and M. Du. 2008. AMP-activated protein kinase and adipogenesis in sheep fetal skeletal muscle and 3T3-L1 cells. J. Anim. Sci. 86:1296-1305.
185. Um, S.H., F. Frigerio, M. Watanabe, F. Picard, M. Joaquin, M. Sticker, S. Fumagalli, P.R. Allegrini, S.C. Kozma, J. Auwerx, and G. Thomas. 2004. Absence of S6K1 protects against age-and diet-induced obesity while enhancing insulin sensitivity. Nature 431:200-205.
186. Underwood, K.R., W.J. Means, M.J. Zhu, S.P. Ford, B.W. Hess, and M. Du. 2008. AMP-activated protein kinase is negatively associated with intramuscular fat content in longissimus dorsi muscle of beef cattle. Meat Sci. 79:394-402.
187. van Laack, R.L. and R.G. Kauffman. 1999. Glycolytic potential of red, soft, exudative pork longissimus muscle. J. Animal Sci. 77:2971-2973.
188. Vary, T.C. 2006. IGF-I stimulates protein synthesis in skeletal muscle through multiple signaling pathways during sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290:R313-321.
189. Vary, T.C., G. Deiter, and S.R. Kimball. 2002. Phosphorylation of eukaryotic initiation factor eIF2Bepsilon in skeletal muscle during sepsis. Am. J. Physiol. Endocrinol. Metab. 283:E1032-1039.
190. Vavvas, D., A. Apazidis, A.K. Saha, J. Gamble, A. Patel, B.E. Kemp, L.A. Witters, and N.B. Ruderman. 1997. Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J. Biol. Chem. 272:13255-13261.
191. Wang, X., Z. Hu, J. Hu, J. Du, and W.E. Mitch. 2006. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 147:4160-4168.
192. Weigert, C., M. Dufer, P. Simon, E. Debre, H. Runge, K. Brodbeck, H.U. Haring, and E.D. Schleicher. 2007. Upregulation of IL-6 mRNA by IL-6 in skeletal muscle cells: role of IL-6 mRNA stabilization and Ca2+-dependent mechanisms. Am. J. Physiol. Cell Physiol. 293:C1139-1147.
193. Winder, W.W., and D.G. Hardie. 1999. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol. 277:E1-E10.
194. Winder, W.W., B.F. Holmes, D.S. Rubink, E.B. Jensen, M. Chen, and J.O. Holloszy. 2000a. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J. Appl. Physiol. 88:2219-2226.
195. Winder, W.W., B.F. Holmes, D.S. Rubink, E.B. Jensen, M. Chen, and J.O. Holloszy. 2000b. Chronic chemical activation of AMP-activated protein kinase increases mitochondrial enzymes and GLUT4 in skeletal muscle of resting rats. Diabetes 49:A10.
196. Witczak, C.A., N. Fujii, J. Brandauer, M. Seifert, N. Nozaki, and L.J. Goodyear. 2006. CaMKK alpha activates AMPK signaling in mouse skeletal muscle in vivo. FASEB J. 20:A820-A820.
197. Woods, A., D. Azzout-Marniche, M. Foretz, S.C. Stein, P. Lemarchand, P. Ferre, F. Foufelle, and D. Carling. 2000. Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol. Cell. Biol. 20:6704-6711.
198. Woods, A., K. Dickerson, R. Heath, S.P. Hong, M. Momcilovic, S.R. Johnstone, M. Carlson, and D. Carling. 2005. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2:21-33.
199. Woods, A., S.R. Johnstone, K. Dickerson, F.C. Leiper, L.G.D. Fryer, D. Neumann, U. Schlattner, T. Wallimann, M. Carlson, and D. Carling. 2003a. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13:2004-2008.
200. Woods, A., I. Salt, J. Scott, D.G. Hardie, and D. Carling. 1996. The alpha1 and alpha2 isoforms of the AMPactivated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett. 397:347-351.
201. Woods, A., D. Vertommen, D. Neumann, R. Turk, J. Bayliss, U. Schlattner, T. Wallimann, D. Carlling, and M.H. Rider. 2003b. Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis. J. Biol. Chem. 278:28434-28442.
202. Wu, X.D., H. Motoshima, K. Mahadev, T.J. Stalker, R. Scalia, and B.J. Goldstein. 2003. Involvement of AMPactivated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52:1355-1363.
203. Wullschleger, S., R. Loewith, and M.N. Hall. 2006. TOR signaling in growth and metabolism. Cell 124:471-484.
204. Xie, M., D. Zhang, J.R. Dyck, Y. Li, H. Zhang, M. Morishima, D.L. Mann, G.E. Taffet, A. Baldini, D.S. Khoury, and M.D. Schneider. 2006. A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc. Natl. Acad. Sci. U.S.A. 103:17378-17383.
205. Yamauchi, T., J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B.B. Kahn, and T. Kadowaki. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMPactivated protein kinase. Nature Medicine 8:1288-1295.
206. Yang, W.B., Y.H. Hong, X.Q. Shen, C. Frankowski, H.S. Camp, and T. Leff. 2001. Regulation of transcription by AMP-activated protein kinase — phosphorylation of p300 blocks its interaction with nuclear receptors. J. Biol. Chem. 276:38341-38344.
207. Yoon, M.J., G.Y. Lee, J.J. Chung, Y.H. Ahn, S.H. Hong, and J.B. Kim. 2006. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogenactivated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55:2562-2570.
208. Young, L.H., Y. Renfu, R. Russell, X.Y. Hu, M. Caplan, J.M. Ren, G.I. Shulman, and A.J. Sinusas. 1997. Lowflow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation 95:415-422.
209. Yu, H., N. Fujii, M.F. Hirshman, J.M. Pomerleau, and L.J. Goodyear. 2004. Cloning and characterization of mouse 5′-AMP-activated protein kinase gamma3 subunit. Am. J. Physiol. Cell Physiol. 286:C283-292.
210. Zheng, D.H., P.S. MacLean, S.C. Pohnert, J.B. Knight, A.L. Olson, W.W. Winder, and G.L. Dohm. 2001. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J. Appl. Physiol. 91:1073-1083.
211. Zhou, G.C., R. Myers, Y. Li, Y. L. Chen, X.L. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M.F. Hirshman, L.J. Goodyear, and D.E. Moller. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108:1167-1174.
212. Zhu, M., B. Han, J. Tong, C. Ma, J.W. Kimzey, K.R. Underwood, Y. Xiao, B.W. Hess, S.P. Ford, P.W. Nathanielsz, and M. Du. 2008. AMP-activated protein kinase signalling pathways are down regulated and skeletal muscle development impaired in fetuses of obese, overnourished sheep. J. Physiol. 586:2651-2664.
213. Ziegler, D., M. Reljanovic, H. Mehnert, and F.A. Gries. 1999. alpha-Lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exper. Clin. Endocrinol. Diabetes 107:421-430.
214. Ziegler, D., H. Schatz, F. Conrad, F.A. Gries, H. Ulrich, and G. Reichel. 1997. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients — a 4-month randomized controlled multicenter trial (DEKAN study). Diabetes Care 20:369-373.